Back
Monster Beverage 10K Form
Buy
62
MNST
Monster Beverage
Last Price:
56.5500
Seasonality Move:
2.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-05-07 | 10Q | MNST/Monster Beverage Quarterly |
2021-03-01 | 10K | MNST/Monster Beverage Annual |
2020-11-06 | 10Q | MNST/Monster Beverage Quarterly |
2020-08-06 | 10Q | MNST/Monster Beverage Quarterly |
2020-05-11 | 10Q | MNST/Monster Beverage Quarterly |
2020-02-28 | 10K | MNST/Monster Beverage Annual |
Receive MNST News And Ratings
See the #1 stock for the next 7 days that we like better than MNST
MNST Financial Statistics
Sales & Book Value
Annual Sales: | $6.31B |
---|---|
Cash Flow: | $294.39M |
Price / Cash Flow: | 45.14 |
Annual Sales: | $7.49 |
Price / Book: | 7.55 |
Profitability
EPS (TTM): | 1.35500 |
---|---|
Net Income (TTM): | $1.44B |
Gross Margin: | $3.17B |
Return on Equity: | 20% |
Return on Assets: | 16.78% |
Monster Beverage Earnings Forecast
Key Monster Beverage Financial Ratios
- The Gross Profit Margin over the past 31 years for MNST is 50.30%.
- The Selling, General & Administrative Expenses for MNST have been equal to 0.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of MNST is 18.88% of Total Revenues.
- Per Share Earnings over the last 33 years have been positive in 17 years.
Monster Beverage Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Beverages - Non-Alcoholic |
Sector: | Consumer Defensive |
Current Symbol: | MNST |
CUSIP: | 61174X |
Website: | monsterbevcorp.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.86 |
Quick Ratio: | 3.97 |
Price-to-Earnings
Trailing P/E Ratio: | 50.72 |
---|---|
Forward P/E Ratio: | 31.52 |
MNST Technical Analysis vs Fundamental Analysis
Buy
62
Monster Beverage (MNST)
is a Buy
Is Monster Beverage a Buy or a Sell?
-
Monster Beverage stock is rated a Buy
The current Monster Beverage [MNST] share price is $56.5500. The Score for MNST is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.